A Look Back: Tenuous Oversight of the $12 Billion California Stem Cell and Gene Therapy Agency
The privileged position of CIRM among California's state departments
Seventeen-thousand words control what the California Insitute for Regenerative Medicine (the state stem cell agency) can and cannot do. They were embedded in state law by a tool of direct democracy — the ballot initiative — in 2004 and again in 2020.
The initiatives created, financed and then refinanced the research enterprise in 20…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.